Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis

…, H Furukawa, S Yoshino, M Yukioka, S Tohma… - Nature …, 2003 - nature.com
Individuals with rheumatoid arthritis frequently have autoantibodies to citrullinated peptides,
suggesting the involvement of the peptidylarginine deiminases citrullinating enzymes (…

Transethnic meta-analysis identifies GSDMA and PRDM1 as susceptibility genes to systemic sclerosis

…, H Yanagida, H Furukawa, S Tohma… - Annals of the …, 2017 - ard.bmj.com
Objectives Systemic sclerosis (SSc) is an autoimmune disease characterised by skin and
systemic fibrosis culminating in organ damage. Previous genetic studies including genome-…

[HTML][HTML] MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease

…, S Ottaviani, S Oka, S Tohma… - … England Journal of …, 2018 - Mass Medical Soc
Background Given the phenotypic similarities between rheumatoid arthritis (RA)–associated
interstitial lung disease (ILD) (hereafter, RA-ILD) and idiopathic pulmonary fibrosis, we …

Meta-analysis identifies nine new loci associated with rheumatoid arthritis in the Japanese population

…, T Matsubara, S Wakitani, R Teshima, S Tohma… - Nature …, 2012 - nature.com
Rheumatoid arthritis is a common autoimmune disease characterized by chronic inflammation.
We report a meta-analysis of genome-wide association studies (GWAS) in a Japanese …

Disease Activity Score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DAS28 using …

…, M Yasuda, K Saisho, K Shimada, S Tohma - Annals of the …, 2007 - ard.bmj.com
Objectives: To compare disease activity and the improvement of disease activity evaluated
between by Disease Activity Score 28 using erythrocyte sedimentation rate (DAS28-ESR) …

Current treatments of rheumatoid arthritis: from the 'NinJa'registry

…, T Matsui, K Saisho, S Tohma - Expert Review of Clinical …, 2012 - Taylor & Francis
In this review, recent changes in both treatments and outcomes of rheumatoid arthritis (RA)
in Japan were analyzed by viewing the National Database of Rheumatic Diseases by iR-net, …

[HTML][HTML] Growth retardation in mice lacking the proteasome activator PA28γ

S Murata, H Kawahara, S Tohma, K Yamamoto… - Journal of Biological …, 1999 - ASBMB
The proteasome activator PA28 binds to both ends of the central catalytic machine, known as
the 20 S proteasome, in opposite orientations to form the enzymatically active proteasome. …

Incidence and risk factors for serious infection in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors: a report from the Registry of Japanese …

…, K Saito, M Takeno, T Atsumi, S Tohma… - The Journal of …, 2011 - jrheum.org
Objective. To compare tumor necrosis factor-α (TNF-α) inhibitors to nonbiological disease-modifying
antirheumatic drugs (DMARD) for the risk of serious infection in Japanese patients …

[PDF][PDF] Phase III study of the efficacy and safety of subcutaneous versus intravenous tocilizumab monotherapy in patients with rheumatoid arthritis

…, M Kondo, Y Ueki, M Iwahashi, S Tohma… - Arthritis care & …, 2014 - Wiley Online Library
Objective To evaluate the efficacious noninferiority of subcutaneous tocilizumab injection (TCZ‐SC)
monotherapy to intravenous TCZ infusion (TCZ‐IV) monotherapy in Japanese …

Drug free REmission/low disease activity after cessation of tocilizumab (Actemra) Monotherapy (DREAM) study

…, H Sano, K Takasugi, T Takeuchi, S Tohma… - Modern …, 2014 - Taylor & Francis
Objectives To investigate the duration of remission and low disease activity (LDA) after cessation
of tocilizumab (TCZ) treatment in rheumatoid arthritis patients who showed remission or …